% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • kzoo_man2525 kzoo_man2525 Apr 27, 2013 2:30 AM Flag

    So the worlds doctors are standing up!!!

    Great read right here ... about the cost of a 100k/year cancer drug being overpriced...|mod&par=xfinity

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yep. This article is typical of the reimbursement climate that is evolving. I recently had dinner with my old work associate who works for a large biotech in reimbursement. I brought up the analyst assumptions about $200-$300k per year for a chronic CF treatment. She is very familiar with CF and just scoffed at the notion that government and insurance agencies will ever pay that much. She pointed to the hesitancy that agencies have to pay $100 k for oncology treatments that often are not administered beyond the first year, with some exceptions like leukemia and small cell lung cancer. I honestly don't know where these analysts came up with their assumptions. I wonder if any of them took time to talk to independent reimbursement specialists, insurance providers and physicians. I think that they do a disservice to the public especially with these speculative plays.

89.85-0.78(-0.86%)10:39 AMEDT